Jenya Antonova

Jenya Antonova offers a holistic and strategic approach in HEOR and PRO/COA strategy development and execution. Jenya excels at maximizing the value propositions of pharmaceutical products and driving excellence in PRO/COA strategy. With a background in health economics and outcomes research, Jenya has a strong track record in formulating payer strategies and conducting research in various therapeutic areas. Jenya's expertise lies in navigating HEOR strategy with precision and excellence, regardless of the budget at hand.